Interaction between alpha- and beta-adrenoceptor-mediated cardiovascular effects

Area of Science:

• Pharmacology
• Cardiovascular Physiology

Background:

• Adrenoceptors, including alpha and beta subtypes (alpha 1/alpha 2, beta 1/beta 2), regulate cardiovascular function.
• Selective agonists and antagonists modulate these receptors, influencing physiological responses.
• Understanding receptor subtypes and their locations (pre/postsynaptic) is crucial for predicting drug effects.

Purpose of the Study:

• To review the cardiovascular effects of combined alpha- and beta-adrenoceptor blockade.
• To analyze the interaction between alpha- and beta-adrenoceptor-mediated effects.
• To discuss drugs with dual alpha- and beta-adrenoceptor blocking properties.

Main Methods:

• Literature review and synthesis of existing research on adrenoceptor pharmacology and cardiovascular effects.
• Analysis of predicted physiological outcomes based on adrenoceptor blockade profiles.
• Case study of celiprolol as an example of a combined alpha- and beta-adrenoceptor blocker.

Main Results:

• Comparable alpha- and beta-blockade predicts vasodilation, reduced peripheral resistance, and lower blood pressure, with no reflex tachycardia.
• Blockade of alpha 2- and beta 1-adrenoceptors results in cardiac changes (beta 1), vasodilation (postsynaptic alpha 2), and enhanced noradrenaline release (presynaptic alpha 2).
• Celiprolol exemplifies combined alpha 2- and beta 1-blockade, though its beta 1 antagonism is more potent.

Conclusions:

• Combined alpha- and beta-adrenoceptor blockade has predictable cardiovascular effects, including vasodilation and reduced blood pressure.
• Understanding the interplay between different adrenoceptor subtypes is essential for drug design and therapeutic application.
• The specific profile of combined blockers, like celiprolol, depends on the relative affinities for each receptor subtype.